FDA Approved: KEVZARA — Supplemental Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

FDA approved a supplemental application for KEVZARA (sarilumab) submitted by Sanofi-Aventis U.S. LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• KEVZARA (sarilumab)

Snippet

SUPPL AP for KEVZARA (SARILUMAB)